Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis Patients in Spain: Results of a Multicenter, Observational Study in Routine Clinical Practice (The ORBIT-RA Study).
Hernández-Cruz B, Rosas J, Díaz-Torné C, Belzunegui J, García-Vicuña R, Inciarte-Mundo J, Pons A, Millán AM, Jeria-Navarro S, Valero JA, García-Castañeda N, Valero C, Llorente I, Calvo A, Díaz-Cerezo S, Núñez M. Hernández-Cruz B, et al. Among authors: inciarte mundo j. Rheumatol Ther. 2022 Apr;9(2):589-608. doi: 10.1007/s40744-021-00423-8. Epub 2022 Jan 18. Rheumatol Ther. 2022. PMID: 35041155 Free PMC article.
Correction to: Real-world Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis patients in Spain: Results of a multicenter, observational study in routine clinical practice (The ORBIT-RA Study).
Hernández-Cruz B, Rosas J, Díaz-Torné C, Belzunegui J, García-Vicuña R, Inciarte-Mundo J, Pons A, Millán AM, Jeria-Navarro S, Valero JA, García-Castañeda N, Valero C, Llorente I, Calvo A, Díaz-Cerezo S, Núñez M. Hernández-Cruz B, et al. Among authors: inciarte mundo j. Rheumatol Ther. 2022 Aug;9(4):1245-1246. doi: 10.1007/s40744-022-00463-8. Rheumatol Ther. 2022. PMID: 35653064 Free PMC article. No abstract available.
Serum Calprotectin Versus Acute-Phase Reactants in the Discrimination of Inflammatory Disease Activity in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors.
Inciarte-Mundo J, Victoria Hernández M, Ruiz-Esquide V, Raquel Cabrera-Villalba S, Ramirez J, Cuervo A, Pascal M, Yagüe J, Cañete JD, Sanmarti R. Inciarte-Mundo J, et al. Arthritis Care Res (Hoboken). 2016 Jul;68(7):899-906. doi: 10.1002/acr.22795. Arthritis Care Res (Hoboken). 2016. PMID: 26841119 Free article.
Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity.
Inciarte-Mundo J, Ramirez J, Hernández MV, Ruiz-Esquide V, Cuervo A, Cabrera-Villalba SR, Pascal M, Yagüe J, Cañete JD, Sanmarti R. Inciarte-Mundo J, et al. Arthritis Res Ther. 2016 Jul 8;18(1):160. doi: 10.1186/s13075-016-1032-z. Arthritis Res Ther. 2016. PMID: 27391315 Free PMC article.
Calprotectin strongly and independently predicts relapse in rheumatoid arthritis and polyarticular psoriatic arthritis patients treated with tumor necrosis factor inhibitors: a 1-year prospective cohort study.
Inciarte-Mundo J, Ramirez J, Hernández MV, Ruiz-Esquide V, Cuervo A, Cabrera-Villalba SR, Pascal M, Yagüe J, Cañete JD, Sanmarti R. Inciarte-Mundo J, et al. Arthritis Res Ther. 2018 Dec 13;20(1):275. doi: 10.1186/s13075-018-1764-z. Arthritis Res Ther. 2018. PMID: 30545393 Free PMC article.
27 results